Summa Equity has agreed to sell HyTest to Mindray for 545 million euros. William Blair has been acting as financial advisor to HyTest on the deal while Avance was legal advisor. Mindray is a global ...

Summa Equity will become majority shareholder of the Finnish company HyTest, producer of antibodies and antigens for the diagnostic industry. The growing company operates in a global market where ...

BEIJING (Reuters) - China's Shenzhen Mindray Bio-Medical Electronics has agreed to acquire HyTest, a supplier of raw materials used in tests for diseases such as COVID-19, to gain independence in ...

Mindray's purchase of Finland-based HyTest Invest Oy and its subsidiaries for an estimated 545 million euros ($661 million), agreed to in a signing on May 15, would give it the resources of a major ...